Avrobio Inc is a clinical-stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. The company manufactures products include AVR-RD-02, AVR-RD-03, and AVR-RD-04 which are used for various diseases such as Fabry, Gaucher, Pompe, and Cystinosis.
If you want more trading ideas like this one,π― press a thumb up! π Have a question? Don't be shy to ask! π€ Interested to study how to analyze charts, follow me!
If you want more trading ideas like this one,π― press a thumb up! π Have a question? Don't be shy to ask! π€ Interested to study how to analyze charts, follow me!